Skip to main content
Clinical Trials/NCT07321275
NCT07321275CompletedNot Applicable

Ultra-early Chest CT Improves Risk Prediction of Stroke-associated Pneumonia: Model Development and External Validation in a Multicentre Retrospective Study

Capital Medical University5 sites in 1 country1,499 target enrollmentStarted: January 15, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,499
Locations
5
Primary Endpoint
Stroke-associated pneumonia

Study Overview

Brief Summary

Stroke-associated pneumonia (SAP) is a common and serious complication after acute ischaemic stroke (AIS). Existing scores rely mainly on clinical variables, and the added prognostic value of inflammatory markers and early chest CT findings remains uncertain. We developed and externally validated an early multimodal model combining clinical severity, inflammation, and chest CT abnormalities, and explored risk-stratified associations between prophylactic antibiotics and SAP.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients aged ≥18 years;
  • Admitted to a participating stroke centre with neuroimaging-confirmed acute ischaemic stroke ;
  • Had chest CT performed within 24 hours of stroke onset.

Exclusion Criteria

  • Chest CT images unavailable or incomplete for assessment;
  • Insufficient clinical documentation to ascertain stroke-associated pneumonia occurrence within 7 days after stroke onset

Arms & Interventions

Development (Derivation) cohort

External validation cohort

Outcomes

Primary Outcomes

Stroke-associated pneumonia

Time Frame: within 7 days after stroke onset

SAP was defined as pneumonia occurring within 7 days after stroke onset. Potential events were screened using discharge diagnosis codes and medical record documentation, and then confirmed by manual chart review using prespecified clinical, laboratory, and radiological criteria consistent with the Pneumonia in Stroke Consensus Group and modified CDC definitions.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Capital Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ji Xunming,MD,PhD

Professor of Neurology, Xuanwu Hospital, Capital Medical University

Capital Medical University

Study Sites (5)

Loading locations...

Similar Trials